. They often involve relatively small numbers of patients and do not provide the same level of evidence as large randomized trials. A response seen in an early study may not transl

Title: Daraxonrasib: Why This Investigational RAS Drug MattersDaraxonrasib, also known by its development code RMC-6236, is an investigational cancer medicine designed to interfere